Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Progesterone Supplementation in Women With Preterm Labor
NCT07523295Phase 4Completed
- Sponsor
- Medicare Hospital
- Start
- May 2025
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of progesterone in Preterm labor (PTL) (2 arms), sponsored by Medicare Hospital. Primary endpoint: Latency Period up to 13 weeks. Started May 2025; status: completed.
02
Drugs
progesterone
03
Conditions
Preterm labor (PTL)
Beyond the preview
Go deeper on NCT07523295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07523295.